Freenome的动态

Today, on Stand Up To Cancer Research Day, we’re reminded of the power of early detection. Oral cancer screenings are a vital tool in the fight against cancer, helping identify potential issues before they become life-threatening. By catching oral cancer early, we increase the chances of successful treatment and a healthier future. Join us in standing up to cancer by scheduling your screening today and supporting the ongoing research that saves lives! Stand Up To Cancer was created to accelerate groundbreaking cancer research that will get promising new cancer treatments to patients quickly. We won’t stop until every cancer patient is a long-term cancer survivor.#StandUpToCancer #OralHealthcare #OralCancerScreening #SU2C #WeKeepPeopleSmiling

Early detection of lung cancer saves lives. Low-dose CT is a safe and painless screening recommended for individuals who meet eligibility criteria for being at high-risk of developing lung cancer. The cancer screening work group within the National Partnership has compiled the following resources to help cancer coalitions in promoting and supporting members with lung cancer screening efforts. https://bit.ly/4exlNbN #TAPintoCancerControl #tapforlungcancer #gwccTAP #LungCancer

Annual lung cancer screenings using low-dose computed tomography (also referred to as LDCT) reduce lung cancer deaths by up to 20%, yet less than 6% of eligible Americans get screened routinely, according to the American Cancer Society. Early detection saves lives; if you meet the criteria, we encourage you to schedule a lung cancer screening at Saint Peter’s this #LungCancerAwarenessMonth. To learn more about lung screenings at Saint Peter's, click the link: https://bit.ly/48G2Wd0

Did you know according to the World Health Organization’s cancer agency, the International Agency for Research on Cancer (IARC), lung cancer was the most frequently diagnosed cancer in 2022, accounting for nearly 2.5 million new cases, or 12.4% of all cancers worldwide? On this World Lung Cancer Day, we shine light on advancements in diagnostics that aid in the fight against lung cancer. CEA levels measured by Beckman Coulter Diagnostics' Access Immunoassay Analyzers aids in the management of cancer patients in whom changing CEA concentrations have been observed. Explore our immunoassay analyzers for early detection, effective management, and closing the care gap ?? https://bit.ly/3y8S1uQ #WorldLungCancerDay #CEAAssay #Immunoassay #CloseTheCareGap

NEWS: 'Lung cancer is the deadliest of all cancers, and screening could save many lives ? if more people could access it' Informative piece in The Conversation US by pulmonologist Nina Thomas who specializes in screening and diagnosing lung cancer. 'Between 2015 and 2019, survival rates for lung cancer have improved by 22%, in part because of an increase in earlier diagnosis. Most patients with early-stage lung cancer, however, have no symptoms and aren’t diagnosed until they reach more advanced stages that are harder to treat, underlining the need for effective lung cancer screening.' Read the full article here: https://lnkd.in/e6icFEn4 #screening #lungcancerscreening #LungCancerEurope #LuCE #LCSM #cancerscreening

Finding trustworthy health related information on the internet nowadays can feel like finding a needle in a haystack. But, it doesn't have to be. Wire Media has teamed up with the Lung Cancer Foundation of America to develop a newly launched site focused on accessible, comprehensive information on lung cancer. You can read both the latest research and find a lung screening locations nearest you all on one site. You can also find guidance on what to do after you or a loved one has been diagnosed with lung cancer from survivors who have been where you are right now. Getting a lung cancer diagnosis is scary. The Lung Cancer Foundation of America seeks to offer you every lifesaving tool it can. Learn more by clicking on the Lung Cancer Foundation of America site below ?? #lungcancerawareness #websitelaunch https://lcfamerica.org/

Despite recent progress in research and treatment, lung cancer, which includes non-small cell lung cancer (NSCLC), remains one of the leading causes of cancer deaths worldwide. Many cases are diagnosed at advanced stages. From the often-devastating impact on daily life to the need for customized care plans, the journey for advanced NSCLC is deeply personal. We, too, take lung cancer personally, driving our commitment to spread awareness and propel research forward for the millions impacted by the disease around the world. #WorldLungCancerDay

Did you know according to the World Health Organization’s cancer agency, the International Agency for Research on Cancer (IARC), lung cancer was the most frequently diagnosed cancer in 2022, accounting for nearly 2.5 million new cases, or 12.4% of all cancers worldwide? On this World Lung Cancer Day, we shine light on advancements in diagnostics that aid in the fight against lung cancer. CEA levels measured by Beckman Coulter Diagnostics' Access Immunoassay Analyzers aids in the management of cancer patients in whom changing CEA concentrations have been observed. Explore our immunoassay analyzers for early detection, effective management, and closing the care gap ?? https://bit.ly/3y8S1uQ #WorldLungCancerDay #CEAAssay #Immunoassay #CloseTheCareGap

November is Lung Cancer Awareness Month—a time to recognize innovative research in the fight against lung cancer. At Adela, we’re committed to advancing breakthroughs that enable earlier diagnosis and improved management of cancer, giving patients a better chance at successful outcomes. Our team works tirelessly to develop and refine methods that can detect cancer and cancer recurrences at their earliest stages, when intervention is most effective. We invite you to visit our website to explore our latest publications and learn more about how we’re contributing to a future where early detection and cancer surveillance saves lives. ? ? Together, let’s continue the journey towards a world with fewer cancer diagnoses and more hope. #LungCancerAwareness #EarlyDetection #CancerResearch??

November is Pancreatic Cancer Awareness Month. While survival rates have improved for many types of cancer, sadly, the same can’t be said for pancreatic cancer. It is often detected so late that more than half of those diagnosed die within three months. Approximately 10,500 people are diagnosed with pancreatic cancer in the UK each year, making it the 10th most common cancer. Although often overlooked, with increased awareness, we can hopefully detect, diagnose, and treat pancreatic cancer sooner. With more funding directed towards research for this devastating disease, we can work together toward a brighter future and save many lives each year! #PancreaticCancerAwarenessMonth #PancreaticCancerAwareness #SavingLives #AlchemistConsulting #Alchemist